Download - Tuberculosis and Leprosy
![Page 1: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/1.jpg)
Tuberculosis – an overview
Presented by: Dave Jay S. Manriquez RN.
February 1, 2009
![Page 2: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/2.jpg)
TB - Prevalence
• 1/3rd of humanity (2 billion people) infected
• One new infection every second
• 8.8 million new cases per year
• 1.6 million deaths/year
• Kills more humans per year than any other infectious disease
![Page 3: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/3.jpg)
TB – worldwide distribution
![Page 4: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/4.jpg)
Estimated Tuberculosis Case Rates, 1997
• India 1,799,000• China: 1,402,000• Indonesia: 583,000• Bangladesh: 300,000• Pakistan: 261,000• Nigeria 253,000• Philippines 222,000• South Africa 170,000• Russian Federation 156,000• Ethiopia 156,000• Vietnam 145,000• Democratic Republic of Congo 129,000
• Adapted from Dye C, Scheele S, Dolin P, et al. Consensus statement. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA. 1999;282:677–686.
![Page 5: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/5.jpg)
TB global stats
• 1/3rd of all new incident cases in Asia
• ½ of all deaths from tb occur in Asia
• In Africa, grew rapidly over last two decades due to HIV
• Period of decline, altered by worldwide epidemic of HIV
![Page 6: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/6.jpg)
Bach Christian Hospital TB stats (2002)
• 141 new cases of tuberculosis (over 11 new cases per month)
• 840 total TB patients under treatment
• 100 patients discharged having completed treatment
![Page 7: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/7.jpg)
TB and HIV
![Page 8: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/8.jpg)
Tuberculosis and HIV
- over 8 million coinfected
- reactivation rates 20 times higher than in non HIV-infected persons
- 50% with dual infection develop active tb
![Page 9: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/9.jpg)
Tuberculosis - resistance
- ½ of all new cases have some resistance
- Worst in 6 Asian countries of Bangladesh, China, India, Indonesia, Pakistan and Philippines
- Every country has resistance to at least one single drug
![Page 10: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/10.jpg)
MDR Tuberculosis
• Defined as resistance to at least INH and rifampicin
• 450,000 cases per year
• XDR – extensive drug resistance – Generally where there is also HIV
![Page 11: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/11.jpg)
Tuberculosis MDR distribution
• Highest in former USSR and China
![Page 12: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/12.jpg)
Mycobacterium others, generally opportunistic and assoc. with HIV
M. Avium Intracellulare
M. Asiaticum
M. Flavenscens
M. fortuitum complex
M. Heamophilum
M. Kanasasii
M. Malmoense
M. Marinum
M. Scrofulaceum
M. Simiae
M. Genavense
M. xenopi
![Page 13: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/13.jpg)
Mycobacterium tuberculosis- the pathogen – AFB staining
![Page 14: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/14.jpg)
Mycobacterium tuberculosis – immune response
• Principle response is formation of a granuloma – monocyte and t cells are with multi-nucleated giant cells on the edge of an area of caseation
• Caseous necrosis and calcium deposition
![Page 15: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/15.jpg)
Tuberculosis - pathology
• Caseous necrosis in kidney
![Page 16: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/16.jpg)
Tuberculosis – clinical presentation
• Primary tb in childhood– Inhalation of organisms– Formation of hilar LAD– Only 5% develop symptomatic disease– 30% develop established infection– 3-5% chance of reactivation– 1/3rd of adult presentations due to new
infection
![Page 17: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/17.jpg)
Primary Tuberculosis-hilar adenopathy and infiltrate
![Page 18: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/18.jpg)
Pulmonary Tuberculosis
• Most cases reactivation of disease acquired years earlier
• Predominant symptoms of cough (78%), weight loss (74%), fatigue (68%), fever (60%), night sweats (55%), hemoptysis (33%)
![Page 19: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/19.jpg)
Pulmonary Tuberculosis – CXR findings
• Apical lesions – mod. and severe w/cavity
![Page 20: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/20.jpg)
Chest X-Ray findings, atypical
• Pneumonic consolidation
![Page 21: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/21.jpg)
Pulmonary Tuberculosis – pleural effusion
• Usually appear 3-6 months after primary disease
• With or without lung infection
• Usually unilateral
• Predominance of lymphs
• Exudative w/protein >3 gms/dl
• Often AFB neg, cx positive
![Page 22: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/22.jpg)
Miliary tuberculosis
• In immune-suppressed
• Follows blood-borne dissemination
• May present as FUO• High mortality rate
![Page 23: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/23.jpg)
Miliary Tuberculosis - choroidal
![Page 24: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/24.jpg)
Extra-pulmonary TBScrofula (lymphadenitis)
• most frequent extrapulmonary manifestation
• 80% cervical• Nearly always PPD
positive• Granulomas on
biopsy• Persistent nodes after
tx common
![Page 25: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/25.jpg)
Extrapulmonary tb - GI
• Anywhere from mouth to anus
• 70% w/advanced pulmonary get GI
• Small bowell- ileocecal valve
• Perforations common• Responds well to tx
![Page 26: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/26.jpg)
tapeworms roundworms
![Page 27: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/27.jpg)
Extrapulmonary TB - peritonitis
• Ascites, pain, +/- fever, wt. loss
• Ascitic fluid seldom AFB positive
• Culture positive in only 25%
• Need tissue biopsy
• Diagnosis often delayed
![Page 28: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/28.jpg)
Extrapulmonary TB - meningitis
• In early childhood, post-primary
• May present with subtle symptoms
• 3/4ths with miliary pattern on CXR
• AFB positive in 37% initially, 90% after 4th spinal tap
![Page 29: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/29.jpg)
Extrapulmonary TB – osteomyelitis
• Pott’s most common – 50% of all osteo
• Low thoracic most common
• Anterior destruction
![Page 30: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/30.jpg)
Extrapulmonary TB - arthritis
• Chronic, progressive, monoarticular
• Usually hip or knee
• AFB positive in only 1/4th
• Ideally, synovial biopsy
![Page 31: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/31.jpg)
Extrapulmonary TB – cold abscesses
![Page 32: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/32.jpg)
Extrapulmonary TB - urogenital
• Often asymptomatic, but kidney most commonly affected
• May present with cystitis symptoms, sterile pyuria
• Cultures 90% sensitive
• Males – scrotal mass, oligospermia
• Female – infertility with hematogenous focus in endosalpinx
![Page 33: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/33.jpg)
Tuberculosis – laboratory investigations
• AFB – inexpensive
• Cultures – expensive, sensitivities helpful in MDR
• PCR – out of reach in poorer countries
• ESR – inexpensive and helpful, decreases with treatment
• Anemia of chronic disease
![Page 34: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/34.jpg)
Tuberculosis - PPD
• 10mm – 90% infected
• >15mm – virtually all
• 5-10mm – may be result of BCG
• Unless recent BCG administration, if >10mm, then not from BCG
![Page 35: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/35.jpg)
BCG vaccine
• Routinely administered in much of the world
• Efficacy 60-80%, though not uniformly
![Page 36: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/36.jpg)
Tuberculosis - treatment
• INH (isoniazid) – bactericidal– Most common side effect hepatotoxicity – Check LFTs (20% of patients)– If occurs, may reintroduce one med at a time– Other side effect – peripheral neuritis,
prevented by coadministration of piridoxine
![Page 37: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/37.jpg)
Tuberculosis - treatment
• Rifampin– Bactericidal– Many interactions with other drugs– Hepatotoxicity
![Page 38: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/38.jpg)
![Page 39: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/39.jpg)
Tuberculosis - treatment
• Pyrizinimide– GI intolerance– Hepatotoxicity – from elevated transaminases
to liver failure
![Page 40: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/40.jpg)
Tuberculosis - treatment
• Ethambutol
-bactericidal
-side effect – retrobulbar neuritis, presenting initially with blurred vision
![Page 41: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/41.jpg)
Tuberculosis – treatment
• Streptomycin– First antituberculous med– Side effects of ototoxicity, nephrotoxicity– Given IM
![Page 42: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/42.jpg)
Tuberculosis – treatmentSecond line drugs
• Ethionamide
• Ciprofloxacin
• Capreomycin
• Kanamycin
• Amikacin
• Cycloserine
• Thiacetazone
![Page 43: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/43.jpg)
Tuberculosis – treatment
• Bacteria killed over 6-mo period, but patient clinically improves in a few weeks
• Can do a 1-3 month interval AFB or culture evaluation
• Can follow ESR/weights
![Page 44: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/44.jpg)
Tuberculosis - treatment
• Variety of regimens• BCH regimen
- for first 2 months, four drugs (INH/rifampin, pyrizinamide, ethambutal- next four months, only INH/rifampin
- CNS – 12 months - depending on clinical scenario DOTS Use of steroids
![Page 45: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/45.jpg)
Leprosy
• Organism – mycobacterium leprae
• Infection of skin and nerves
![Page 46: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/46.jpg)
Leprosy
Prevalence - 10-15 million in 1950s - 600,000 in 2000 Countries affected (>1/10,000) 122 in 1985 15 in 200083% in India, Brazil, Myanmar, Madagascar,
Nepal, Mozambique
![Page 47: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/47.jpg)
Leprosy - transmission
• Generally nasal secretions, particularly in lepromatous
• Importance of proximity, but most cases sporadic
![Page 48: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/48.jpg)
Leprosy - presentation
• Subclinical more common than clinical, as incubation 4-10 years
• Clinical – tuberculoid vs. lepromatous
![Page 49: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/49.jpg)
![Page 50: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/50.jpg)
Leprosy – clinical presentation
• Tuberculoid – limited by vigorous cell-mediated response
• Lepromatous – proliferation of bacteria with extensive skin and nerve involvement
![Page 51: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/51.jpg)
Leprosy - tuberculoid
![Page 52: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/52.jpg)
Leprosy - lepromatous
![Page 53: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/53.jpg)
Leprosy - lepromatous
![Page 54: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/54.jpg)
![Page 55: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/55.jpg)
Leprosy – borderline tuberculoid
![Page 56: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/56.jpg)
Leprosy – mid borderline
![Page 57: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/57.jpg)
![Page 58: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/58.jpg)
Leprosy – clinical presentation
• Reversal reactions– Occur in all forms except polar tuberculoid– Sometimes after initiation of treatment– Inflammation of existing lesions or new skin
lesions, may present with acutely swollen nerves
– Respond to steroids
![Page 59: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/59.jpg)
Leprosy – reversal reactions
![Page 60: Tuberculosis and Leprosy](https://reader035.vdocument.in/reader035/viewer/2022062307/5555cea8d8b42a711f8b492d/html5/thumbnails/60.jpg)
Leprosy - treatment
• Combination therapy with dapsone, rifampin, clofazimine, quinolones, minocycline, azithromycin
• Multibacillary vs. paucibacillary
• High dose steroids for reversal reactions